 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - G1 Therapeutics Inc. (GTHX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-09-04 Purchase | 2020-09-08 8:38 pm | G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel | 1,000 | $14.95 | $14,950 | 4,000 (Direct) | View |
| 2020-11-10 Purchase | 2020-11-13 4:33 pm | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. Director | 8,000 | $12.8 | $102,375 | 8,000 (Direct) | View |
| 2020-11-18 Purchase | 2020-11-19 4:54 pm | G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director | 50,000 | $13.5 | $675,000 | 170,969 (Direct) | View |
| 2020-12-01 Sale | 2020-12-03 4:20 pm | G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director | 520 | $20.09 | $10,449 | 57,762 (Indirect) | View |
| 2020-12-08 Sale | 2020-12-10 5:30 pm | G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director | 19,480 | $20.22 | $393,899 | 38,282 (Indirect) | View |
| 2020-12-10 Sale | 2020-12-11 4:50 pm | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 9,000 | $20.06 | $180,550 | 29,200 (Direct) | View |
| 2020-12-15 Sale | 2020-12-17 6:01 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 30,000 | $19.53 | $585,986 | 37,000 (Direct) | View |
| 2020-12-22 Sale | 2020-12-23 6:54 pm | G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director | 32,092 | $20.27 | $650,458 | 6,190 (Indirect) | View |
| 2020-12-24 Sale | 2020-12-29 4:50 pm | G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director | 924 | $20.1 | $18,572 | 5,266 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-07-18 Exercise | 2019-07-19 9:58 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,000 | $3.72 | 6,333 (Direct) | View |
| 2019-07-18 Exercise | 2019-07-19 9:58 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,000 | $3.72 | 6,333 (Direct) | View |
| 2019-07-29 Option Award | 2019-07-30 4:29 pm | N/A 2029-07-29 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 300,000 | $25.72 | 300,000 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:58 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 5,000 | $0.39 | 85,444 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:58 pm | N/A 2024-07-11 | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 5,000 | $0.39 | 85,444 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:58 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 1,000 | $3.72 | 5,333 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:58 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 1,000 | $3.72 | 5,333 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:59 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 6,000 | $0.39 | 374,286 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:59 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 6,000 | $0.39 | 374,286 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:14 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 220,000 | $21.08 | 220,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:14 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 80,000 | $21.08 | 80,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:14 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 60,000 | $21.08 | 60,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:14 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L COO | 60,000 | $21.08 | 60,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:15 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel | 60,000 | $21.08 | 60,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:15 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | DEMAREE JOHN Chief Commercial Officer | 30,000 | $21.08 | 30,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:15 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 60,000 | $21.08 | 60,000 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-13 4:02 pm | N/A 2030-03-12 | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. Director | 40,000 | $12 | 40,000 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 3,000 | $0.39 | 371,286 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 3,000 | $0.39 | 371,286 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 2,500 | $0.39 | 82,944 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A 2024-07-11 | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 2,500 | $0.39 | 82,944 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,000 | $3.72 | 3,333 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 2,000 | $3.72 | 3,333 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-01 4:53 pm | N/A 2030-03-31 | G1 Therapeutics Inc. | GTHX | Gupta Soma Chief Commercial Officer | 300,000 | $11.02 | 300,000 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-12 4:32 pm | N/A 2030-06-11 | G1 Therapeutics Inc. | GTHX | ESHELMAN FREDRIC N Director | 20,000 | $17.59 | 20,000 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-12 4:34 pm | N/A 2030-06-11 | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. Director | 20,000 | $17.59 | 20,000 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-12 4:37 pm | N/A 2030-06-11 | G1 Therapeutics Inc. | GTHX | Deese Willie A Director | 20,000 | $17.59 | 20,000 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-12 4:38 pm | N/A 2030-06-11 | G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director | 20,000 | $17.59 | 20,000 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-12 4:39 pm | N/A 2030-06-11 | G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director | 20,000 | $17.59 | 20,000 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-12 4:40 pm | N/A 2030-06-11 | G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director | 20,000 | $17.59 | 20,000 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-12 4:42 pm | N/A 2030-06-11 | G1 Therapeutics Inc. | GTHX | Schwalm Cynthia Director | 20,000 | $17.59 | 20,000 (Direct) | View |
| 2020-12-10 Exercise | 2020-12-11 4:50 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 9,000 | $4.17 | 29,200 (Direct) | View |
| 2020-12-10 Exercise | 2020-12-11 4:50 pm | N/A 2026-05-10 | G1 Therapeutics Inc. | GTHX | Malik Rajesh VP | 9,000 | $4.17 | 29,200 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 6:01 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 10,000 | $3.72 | 37,000 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 6:01 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 10,000 | $3.72 | 37,000 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 6:01 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 10,000 | $3.72 | 37,000 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 6:01 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 10,000 | $3.72 | 37,000 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 6:01 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 10,000 | $3.72 | 37,000 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 6:01 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. CEO | 10,000 | $3.72 | 37,000 (Direct) | View |
| 2021-01-01 Option Award | 2021-01-05 5:09 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. CEO | 213,333 | $0 | 320,000 (Direct) | View |
| 2021-01-01 Option Award | 2021-01-05 5:09 pm | N/A 2031-01-01 | G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. CEO | 320,000 | $17.99 | 320,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:10 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 11,000 | $0 | 58,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:10 pm | N/A 2031-01-04 | G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer | 58,000 | $18.07 | 58,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:12 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L COO | 11,000 | $0 | 58,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:12 pm | N/A 2031-01-04 | G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L COO | 58,000 | $18.07 | 58,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:14 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 11,000 | $0 | 58,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:14 pm | N/A 2031-01-04 | G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer | 58,000 | $18.07 | 58,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:18 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel | 11,000 | $0 | 58,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:18 pm | N/A 2031-01-04 | G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel | 58,000 | $18.07 | 58,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:22 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Gupta Soma Chief Commercial Officer | 11,000 | $0 | 58,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:22 pm | N/A 2031-01-04 | G1 Therapeutics Inc. | GTHX | Gupta Soma Chief Commercial Officer | 58,000 | $18.07 | 58,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:25 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 11,000 | $0 | 58,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 6:25 pm | N/A 2031-01-04 | G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO | 58,000 | $18.07 | 58,000 (Direct) | View |